Rolfe Foundation Helps Fund Seventh Annual Team Science Award Winners
“This is a talented group of scientists with a shared goal — alleviating the suffering caused by pancreatic cancer,” said Hruban, professor of pathology and oncology at Johns Hopkins University.
Read entire article.
Scientists Find Loophole inPancreatic Cancer Defenses
Dana-Farber Cancer Institute scientists and colleagues have discovered that pancreatic cancer cells’ growth and spread are fueled by an unusual metabolic pathway that someday might be blocked with targeted drugs to control the deadly cancer.
Read entire article.
Pap Test Could Help Find Cancers of Uterus and Ovaries
Below is a link to a recent New York Times article reporting on a paper published by Burt Vogelstein's group at Johns Hopkins in which they applied next-generation sequencing to Pap smears and showed they could detect mutant DNA from endometrial and, in some cases, even ovarian cancer. This is the same approach that the pancreatic cancer lab at Johns Hopkins, headed by Ralph Hruban, is applying to pancreatic cysts and hopefully, one day, to duodenal fluid and even blood as a screening test for pancreatic cancer.
Read entire article.
Oral Bacteria Linked to Increased Risk of Pancreatic Cancer
"Certain types of bacterium present in the formation of gum disease is linked to a 2 times higher risk of developing pancreatic cancer."
Read entire article.
Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development
Like bad traffic, surgery is something to be avoided if at all possible.
Read entire article.
Urine test could hold key to early cancer diagnosis
"The findings could help the detection of [pancreatic] cancer in people who have not yet started to show symptoms."
"It would enable patients to be diagnosed much earlier, leading to improved survival rates."
Read entire article.
FDA approves new pancreatic cancer drug
"Data show Afinitor delays tumor growth and reduces risk of disease progression in patients with advanced neuroendocrine tumors (NET) of pancreatic origin," the Swiss drugmaker said in a statement.
"This marks the first approval of a treatment for this patient population in the United States in nearly 30 years."
Read entire article.
Decoding tumors in search of more effective cancer treatments
See article in LA Times about Rolfe-funded scientist, Kevin Roggin and his collaboration with Kevin White in The University of Chicago's Institute for Genomics and Systems Biology.
Read entire article.